Meaningful Retrospective Analysis

Published on 27/03/2015 by admin

Filed under Neurosurgery

Last modified 27/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1234 times

Chapter 211 Meaningful Retrospective Analysis

Today, there is a growing need to supplement our education with a systematic understanding of the principles of evidence-based practice. In this chapter, we explore the value of the retrospective approach and learn how to interpret clinical evidence when the clinical data are not randomized, or even prospective. New approaches using modern statistical methods with administrative databases have improved our ability to extract meaningful conclusions from retrospective data. By understanding both the strengths and weaknesses of the retrospective study, we can learn to harness the power of the approach without falling prey to false conclusions. Indeed, there is a role for retrospective studies, and it is likely that the approach will have a lasting presence in understanding outcomes from spine surgery.

Retrospective Clinical Studies

Retrospective studies represent a major portion of the available evidence in neurologic surgery. Although these types of studies constitute level III or IV evidence (Oxford Center for Evidence-based Medicine Levels of Clinical Evidence [Table 211-1]), they nonetheless represent the majority of neurosurgery evidence to date. There are three major types of nonrandomized clinical studies:

TABLE 211-1 Medical Levels of Clinical Evidence

Level of Clinical Evidence Description
I Well-executed randomized controlled trial
II Prospective cohort study with controls
III Case-control study
IV Case series (without control group)
V Expert opinion or theory

Modified from Oxford Centre for Evidence-based Medicine Levels of Evidence and Grades of Recommendation, 2001. http://www.cebm.net/index.aspx?0=5513.

In some situations, it is advantageous to compare the outcomes from one cohort with those from a cohort treated previously. Fessler et al.’s classic paper comparing corpectomy outcomes to cervical laminectomy outcomes (Nurick grade) is an example.3

Limitations of Randomized Clinical Trial Methodology

Although the randomized clinical trial (RCT) represents the highest level of clinical evidence, significant barriers exist to performing an RCT in spine surgery. The heterogeneity of spine diseases, the requirement for equipoise, and the learning curve associated with novel procedures are often cited as common challenges in performing RCTs. Even when performed, the results of RCTs are difficult to interpret or do not provide a clear answer to the research question (see Chapter 210). For these and many other reasons, nonrandomized clinical studies including retrospective studies remain an important research tool for spine surgeons. In fact, the number of published retrospective clinical studies continues to increase (Fig. 211-1). Prospective registries may represent an alternative to the RCT, although they pose the risk of generating data that can be difficult to interpret without clearly defined entry and exclusion criteria and control groups.

Advantages of Retrospective Methodology

Retrospective studies may, in some situations, evaluate more diverse patient populations and, as a result, provide data that more closely informs actual clinical practice. A study by Glassman et al. evaluated the effect of sagittal imbalance on health status by retrospectively reviewing 752 patients with various degrees of adult deformity. The study demonstrated that increasing sagittal imbalance correlates with worsening health status.4 In a companion study, Glassman et al. further identified sagittal imbalance as a reliable predictor of clinical symptoms relative to a number of other patient characteristics.5 Although the associations identified in these retrospective studies could not establish cause and effect, they are very useful for practicing spine surgeons interested in treating spine deformity.

Retrospective studies and prospective clinical trials can be viewed as working cooperatively to provide comprehensive evidence. Retrospective studies represent the observational first step that is critical for uncovering patterns among a vast array of patient factors and outcomes.6 From these patterns, hypotheses can be generated to identify potential causal relationships. RCTs alternatively represent the scientific experimentation step that either confirms or refutes these causal relationships. RCTs are well suited to test the effectiveness of an intervention by controlling for differences in baseline patient characteristics; however, retrospective studies are often very useful for identifying which patient characteristics are the most relevant in predicting outcomes. Both observation and experimentation steps are essential for scientific advancement.

The primary utility of the retrospective study is in identifying patterns among patient characteristics (e.g., risk factors, prognostic indicators) and their potential effect on clinical outcomes. This advantage is particularly evident in studying infrequent or delayed outcomes. For example, Cammisa et al. retrospectively reviewed 2144 patients treated over a 9-year period to identify factors associated with an incidental durotomy. They identified a 3.1% rate of durotomy in spine surgery patients.7 They found that incidental durotomies occurred more frequently in patients with prior surgery, and, that overall, with appropriate repair, patients with durotomies did not suffer any long-term sequelae compared with patients without durotomy. An RCT to address this particular question would have required 10 years to perform and likely would have cost millions of dollars.

Adjacent-level disease is another example of a relatively low-frequency event following spine surgery that has been studied using retrospective studies. The concept (although it is controversial) has fueled the development of motion-preservation techniques in spine surgery. In a landmark paper, Hilibrand et al. retrospectively evaluated 374 patients for delayed incidence of adjacent-segment degeneration following anterior cervical fusion up to 10 years postoperatively.8

Buy Membership for Neurosurgery Category to continue reading. Learn more here